Alto Ingredients, Inc.

As of March 14, 2023, Alto Ingredients, Inc. is considered overvalued and risky due to poor financial metrics, underperformance compared to peers, and a significant decline in stock value relative to the S&P 500.

As of March 14, 2023, Alto Ingredients, Inc. is considered overvalued and risky, with poor financial ratios and a year-to-date stock performance of -28.85%, contrasting sharply with its peers and the S&P 500.

As of June 3, 2025, the trend is mildly bearish due to daily moving averages and Bollinger Bands signaling bearishness, despite some mildly bullish indicators like the MACD and KST, while the stock has significantly underperformed the S&P 500.

As of March 2022, the management team of Alto Ingredients, Inc. includes Independent Chairman William Jones, President and CEO Michael Kandris, and several Independent Directors: Douglas Kieta, Gilbert Nathan, Dianne Nury, John Prince, and Terry Stone. The team comprises both executive leadership and independent directors.

Alto Ingredients, Inc. is a micro-cap producer of specialty alcohols and essential ingredients in the specialty chemicals industry, with recent net sales of $227 million and a net loss of $12 million. The company has a market cap of $91.11 million and key metrics indicating financial challenges, including a negative return on equity of -18.96%.

As of Jun 18, Alto Ingredients, Inc. has a market capitalization of 91.11 million, with net sales of 951.17 million and a net profit of -58.94 million over the last four quarters.